Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose dobutamine stress echocardiography to assess left ventricular contractile reserve for cardiac resynchronization therapy: data from the Low-Dose Dobutamine Stress Echocardiography to Predict Cardiac Resynchronization Therapy Response (LODO-CRT) trial.
Iacopino S, Gasparini M, Zanon F, Dicandia C, Distefano G, Curnis A, Donati R, Neja CP, Calvi V, Davinelli M, Novelli V, Muto C. Iacopino S, et al. Among authors: muto c. Congest Heart Fail. 2010 May-Jun;16(3):104-10. doi: 10.1111/j.1751-7133.2010.00141.x. Congest Heart Fail. 2010. PMID: 20557329 Free article.
Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial.
Muto C, Gasparini M, Neja CP, Iacopino S, Davinelli M, Zanon F, Dicandia C, Distefano G, Donati R, Calvi V, Denaro A, Tuccillo B. Muto C, et al. Heart Rhythm. 2010 Nov;7(11):1600-5. doi: 10.1016/j.hrthm.2010.07.036. Epub 2010 Aug 3. Heart Rhythm. 2010. PMID: 20691283 Clinical Trial.
Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study.
Gasparini M, Muto C, Iacopino S, Zanon F, Dicandia C, Distefano G, Favale S, Peraldo Neja C, Bragato R, Davinelli M, Mangoni L, Denaro A. Gasparini M, et al. Among authors: muto c. Am Heart J. 2012 Mar;163(3):422-9. doi: 10.1016/j.ahj.2011.11.015. Epub 2012 Jan 20. Am Heart J. 2012. PMID: 22424013 Clinical Trial.
Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy.
Tuccillo B, Muto C, Iengo R, Accadia M, Rumolo S, Canciello M, Carreras G, Calvanese R, Celentano E, Davinelli M, Valsecchi S, Ascione L. Tuccillo B, et al. Among authors: muto c. J Interv Card Electrophysiol. 2008 Nov;23(2):121-6. doi: 10.1007/s10840-008-9255-9. Epub 2008 Jun 28. J Interv Card Electrophysiol. 2008. PMID: 18587637
Chronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study.
Muto C, Calvi V, Botto GL, Pecora D, Porcelli D, Costa A, Ciaramitaro G, Airò Farulla R, Rago A, Calvanese R, Baratto MT, Reggiani A, Giammaria M, Patané S, Campari M, Valsecchi S, Maglia G. Muto C, et al. Biomed Res Int. 2018 May 22;2018:1404659. doi: 10.1155/2018/1404659. eCollection 2018. Biomed Res Int. 2018. PMID: 29951525 Free PMC article. Clinical Trial.
Right ventricular lead placement and ventricular dyssynchrony in a pacemaker population: An acute analysis from the evaluation of apical and non-apical position (right pace) study.
Muto C, Calvi V, Botto GL, Pecora D, Zuccaro LM, Costa A, Ciaramitaro G, Airò Farulla R, Nigro G, Tuccillo B, Racheli M, Lilli A, Reggiani A, Malacrida M, Valsecchi S, Maglia G. Muto C, et al. Int J Cardiol. 2016 Dec 15;225:296-299. doi: 10.1016/j.ijcard.2016.09.112. Epub 2016 Oct 3. Int J Cardiol. 2016. PMID: 27744206 Clinical Trial. No abstract available.
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group. Padeletti L, et al. Among authors: muto c. Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7. Am Heart J. 2008. PMID: 18760135 Clinical Trial.
Gender-related safety and efficacy of cardiac resynchronization therapy.
Schuchert A, Muto C, Maounis T, Frank R, Ella RO, Polauck A, Padeletti L; MASCOT Study Group. Schuchert A, et al. Among authors: muto c. Clin Cardiol. 2013 Nov;36(11):683-90. doi: 10.1002/clc.22203. Epub 2013 Sep 17. Clin Cardiol. 2013. PMID: 24105909 Free PMC article. Clinical Trial.
113 results